454 related articles for article (PubMed ID: 12500404)
1. [Clinical analysis of 57 patients with ovarian dysgerminoma].
Li YF; Li MD; Wu QL; Liu FY; Li JD; Zou JL; Huang YW
Ai Zheng; 2002 Jan; 21(1):79-82. PubMed ID: 12500404
[TBL] [Abstract][Full Text] [Related]
2. [Early recurrent factors of ovarian cancer after treatment].
Zhang JQ; Li L; Chen XQ
Ai Zheng; 2003 Nov; 22(11):1201-3. PubMed ID: 14613653
[TBL] [Abstract][Full Text] [Related]
3. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
Silva EG; Gershenson DM; Malpica A; Deavers M
Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
[TBL] [Abstract][Full Text] [Related]
4. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY
Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380
[TBL] [Abstract][Full Text] [Related]
5. Pure dysgerminoma of the ovary 35 years on: a single institutional experience.
Vicus D; Beiner ME; Klachook S; Le LW; Laframboise S; Mackay H
Gynecol Oncol; 2010 Apr; 117(1):23-6. PubMed ID: 20097412
[TBL] [Abstract][Full Text] [Related]
6. [Dysgerminoma of the ovary: a clinical retrospective analysis of 60 cases].
Zhang R; Hong W; Li S
Zhonghua Fu Chan Ke Za Zhi; 1995 Sep; 30(9):550-2. PubMed ID: 8556917
[TBL] [Abstract][Full Text] [Related]
7. [Treatment and prognostic factors for stage IV epithelial ovarian cancer].
Wu M; Shen K; Lang J
Zhonghua Fu Chan Ke Za Zhi; 2000 Apr; 35(4):200-3. PubMed ID: 11776158
[TBL] [Abstract][Full Text] [Related]
8. [Treatment and prognosis of stage III-IV laryngeal squamous cell carcinoma].
Tian WD; Zeng ZY; Chen FJ; Wu GH; Guo ZM; Zhang Q
Ai Zheng; 2006 Jan; 25(1):80-4. PubMed ID: 16405756
[TBL] [Abstract][Full Text] [Related]
9. [Prognostic factors in granulosa cell tumor of the ovary].
Wu L; Zhang W; Li L
Zhonghua Fu Chan Ke Za Zhi; 2000 Nov; 35(11):673-6. PubMed ID: 11218897
[TBL] [Abstract][Full Text] [Related]
10. [Study on management of low potential malignancy ovarian tumors].
Takahashi A; Ukita M; Nunotani T; Kanto T; Natsuyama S
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Nov; 41(11):1797-802. PubMed ID: 2592805
[TBL] [Abstract][Full Text] [Related]
11. [Pure ovarian dysgerminoma. Evaluation of experiences and definition of a therapeutic strategy].
Dilhuydy JM; Lagarde P; Chauvergne J; Mongodin B; Dilhuydy MH; Coindre JM; Avril A; Richaud P; Pigneux J
Bull Cancer; 1990; 77(3):213-24. PubMed ID: 2340352
[TBL] [Abstract][Full Text] [Related]
12. Retrospective analysis of 67 consecutive cases of pure ovarian immature teratoma.
Li H; Hong W; Zhang R; Wu L; Liu L; Zhang W
Chin Med J (Engl); 2002 Oct; 115(10):1496-500. PubMed ID: 12490095
[TBL] [Abstract][Full Text] [Related]
13. [Recurrence risk factors of platinum-sensitive epithelial ovarian cancer].
Yan XJ; Liang LZ; Zeng ZY; Liu JH; Yuan SH; Wei M
Ai Zheng; 2005 Jun; 24(6):751-4. PubMed ID: 15946495
[TBL] [Abstract][Full Text] [Related]
14. Dysgerminoma of the ovary.
LaPolla JP; Benda J; Vigliotti AP; Anderson B
Obstet Gynecol; 1987 Jun; 69(6):859-64. PubMed ID: 3574816
[TBL] [Abstract][Full Text] [Related]
15. Dysgerminoma: the role of conservative surgery.
Casey AC; Bhodauria S; Shapter A; Nieberg R; Berek JS; Farias-Eisner R
Gynecol Oncol; 1996 Dec; 63(3):352-7. PubMed ID: 8946871
[TBL] [Abstract][Full Text] [Related]
16. [Characteristics of rare ovarian tumors--possibilities of organ preservation].
Grischke EM; Wallwiener D; Bastert G
Zentralbl Gynakol; 1996; 118(6):322-5. PubMed ID: 8768007
[TBL] [Abstract][Full Text] [Related]
17. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.
Veras E; Deavers MT; Silva EG; Malpica A
Am J Surg Pathol; 2007 May; 31(5):774-82. PubMed ID: 17460463
[TBL] [Abstract][Full Text] [Related]
18. [Clinical picture and treatment of ovarian dysgerminoma patients].
Antoshechkina ET
Vopr Onkol; 1985; 31(3):68-74. PubMed ID: 3992962
[TBL] [Abstract][Full Text] [Related]
19. [An analysis of factors influential in improving the survival rate of patients with ovarian cancer].
Ohta M; Tomoda Y; Kano T
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1008-15. PubMed ID: 2730004
[TBL] [Abstract][Full Text] [Related]
20. Malignant ovarian germ cell tumors: clinico-pathological presentation and survival outcomes.
Tangjitgamol S; Hanprasertpong J; Manusirivithaya S; Wootipoom V; Thavaramara T; Buhachat R
Acta Obstet Gynecol Scand; 2010; 89(2):182-9. PubMed ID: 19961281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
